Abstract:Introduction: Cannabis contains cannabidiol (CBD), the main non-psychoactive phytocannabinoid, but also many other phytocannabinoids that have therapeutic potential in the treatment of epilepsy. Indeed, the phytocannabinoids cannabigerolic acid (CBGA), cannabidivarinic acid (CBDVA), cannabichromenic acid (CBCA) and cannabichromene (CBC) have recently been shown to have anti-convulsant effects in a mouse model of Dravet syndrome (DS), an intractable form of epilepsy. Recent studies demonstrate that CBD inhibits voltage-gated sodium channel function, however, whether these other anti-convulsant phytocannabinoids affect these classic epilepsy drug-targets is unknown. Voltage-gated sodium (Na V ) channels play a pivotal role in initiation and propagation of the neuronal action potential and Na V 1.1, Na V 1.2, Na V 1.6 and Na V 1.7 are associated with the intractable epilepsies and pain conditions. Methods: In this study, using automated-planar patch-clamp technology, we assessed the profile of the phytocannabinoids CBGA, CBDVA, cannabigerol (CBG), CBCA and CBC against these human voltage-gated sodium channels subtypes expressed in mammalian cells and compared the effects to CBD. Results: CBD and CBGA inhibited peak current amplitude in the low micromolar range in a concentration-dependent manner, while CBG, CBCA and CBC revealed only modest inhibition for this subset of sodium channels. CBDVA inhibited Na V 1.6 peak currents in the low micromolar range in a concentration-dependent fashion, while only exhibiting modest inhibitory effects on Na V 1.1, Na V 1.2, and Na V 1.7 channels. CBD and CBGA non-selectively inhibited all channel subtypes examined, whereas CBDVA was selective for Na V 1.6. In addition, to better understand the mechanism of this inhibition, we examined the biophysical properties of these channels in the presence of each cannabinoid. CBD reduced Na V 1.1 and Na V 1.7 channel availability by modulating the voltage-dependence of steady-state fast inactivation (SSFI, V 0.5 inact), and for Na V 1.7 channel conductance was reduced. CBGA also reduced Na V 1.1 and Na V 1.7 channel availability by shifting the voltage-dependence of activation (V 0.5 act) to a more depolarized potential, and for Na V 1.7 SSFI was shifted to a more hyperpolarized potential. CBDVA reduced channel availability by modifying conductance, SSFI and recovery from SSFI for all four channels, except for Na V 1.2, where V 0.5 inact was unaffected. Discussion: Collectively, these data advance our understanding of the molecular actions of lesser studied phytocannabinoids on voltage-gated sodium channel proteins.

Endocannabinoid regulation of inward rectifier potassium (Kir) channels

Receptor-Dependent and Independent Regulation of Voltage-Gated Ca2+ Channels and Ca2+-Permeable Channels by Endocannabinoids in the Brain

Cannabinoid inhibition of mechanosensitive K+ channels

Examining Changes in Gramicidin Current Induced by Endocannabinoids

Lights on Endocannabinoid-Mediated Synaptic Potentiation.

Actomyosin-mediated nanostructural remodeling of the presynaptic vesicle pool by cannabinoids induces long-term depression

Actomyosin-mediated Inhibition of Synaptic Vesicle Release under CB1R Activation.

Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents

Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids

Modulation of the Cys-loop Ligand-Gated Ion Channels by Fatty Acid and Cannabinoids.

Inward Rectifier Potassium Channels: Membrane Lipid-Dependent Mechanosensitive Gates in Brain Vascular Cells

Endocannabinoid Dynamics Gate Spike-Timing Dependent Depression and Potentiation

Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects

Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels

Structural Insights into the Lipid and Ligand Regulation of a Human Neuronal KCNQ Channel

Cannabinoid Receptor Agonists Modulate Calcium Channels in Rat Retinal Müller Cells.

Effects of cannabinoids on ligand-gated ion channels

Cannabinoid CB1 and CB2 Receptors Differentially Modulate L- and T-type Ca2+ Channels in Rat Retinal Ganglion Cells

Ligand activation mechanisms of human KCNQ2 channel

Inhibitory effects of cannabidiol on voltage-dependent sodium currents

Insights into Activation Dynamics and Functional Sites of Inwardly Rectifying Potassium Channel Kir3.2 by an Elastic Network Model Combined with Perturbation Methods